Tests barley fiber supplement for high blood pressure
Tests a highland barley fiber supplement in adults with high blood pressure.
Plain-language title generated from the registry record
Registry title: Effect of Prebiotics on Blood Pressure Management
Key facts
- Where
- Guangzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 65 years old?
Source: NCT05364736, who can take part
Where in China
- Sun Yat-sen UniversityGuangzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sun Yat-sen University
- Trial code
- NCT05364736
- Record updated
- 6 May 2022
- Original description
This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood pressure, gut microbiota and cardiovascular risk fators in subjects with hypertention.Read full original descriptionShow less
An Interventional Study for the Effects of Highland Barley β-glucan on the Management of Hypertension and Cardiovascular Risk
This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood pressure, gut microbiota and cardiovascular risk fators in subjects with hypertention.
Inclusion: Age:30-65 years old; Newly diagnosed hypertension did not use antihypertensive drugs OR Systolic blood pressure ≥140mmHg on the physical examination OR Diastolic blood pressure ≥90mmHg on the physical examination; BMI≥18 kg/m2.
Exclusion: Receiving or have been treated with antihypertensive drugs; Complications including chronic gastrointestinal disease; or suffered from acute gastrointestinal diseases within 1 months before screening visit; Received antibiotics, probiotics within 3 months before screening visit or throughout the trail; Complications including cardiovascular and cerebrovascular diseases such as coronary heart disease and stroke; Autoimmune diseases or thyroid diseases; Malignant disease, infectious disease, inflammatory disease and advanced liver disease; Severe liver or renal insufficiency (alanine aminotransferase, aspartate aminotransferase or alkaline phosphatase is greater than 3 times the upper limit of normal OR GFR<30ml/min/1.73m2); Women who are pregnant, nursing, or prepare to give birth during the trail; Mental or intellectual abnormalities, unable to sign informed consent; Major operations were performed within six months of screening visit, or will be made during the trial; Alcohol abuse (alcohol intake>60g/d for male and alcohol intake>40g/d for female).